Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 260, Issue -, Pages 115772
Publisher
Elsevier BV
Online
2023-08-29
DOI
10.1016/j.ejmech.2023.115772
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses
- (2023) Lucile Brier et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Korupensamine A, but not its atropisomer, korupensamine B, inhibits SARS-CoV-2 in vitro by targeting its main protease (Mpro)
- (2023) Ahmed M. Sayed et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)
- (2023) Chamandi S. Dampalla et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination
- (2023) Irina Stefanelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective
- (2023) Cecilia Pozzi et al. Journal of Medicinal Chemistry
- Discovery of highly potent SARS-CoV-2 Mpro inhibitors based on benzoisothiazolone scaffold
- (2022) Weixiong Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2
- (2022) Bo Hou et al. JOURNAL OF NATURAL PRODUCTS
- Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
- (2022) Andreas Luttens et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selective Covalent Targeting of SARS-CoV-2 Main Protease by Enantiopure Chlorofluoroacetamide
- (2022) Daiki Yamane et al. Chemical Science
- Non-covalent SARS-CoV-2 Mpro inhibitors developed from in silico screen hits
- (2022) Giacomo G. Rossetti et al. Scientific Reports
- Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
- (2022) Pei-Chen Yu et al. Pharmaceutics
- Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection
- (2022) Rui Ge et al. SLAS Discovery
- Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients
- (2022) Ronza Najjar-Debbiny et al. CLINICAL INFECTIOUS DISEASES
- In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease
- (2022) Muya Xiong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
- (2022) Yuto Unoh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine
- (2022) Tika R. Malla et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease
- (2022) Chamandi S. Dampalla et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors
- (2022) Hani A. Alhadrami et al. Marine Drugs
- Reproductive and developmental safety of nirmatrelvir (PF-07321332), an oral SARS-CoV-2 Mpro inhibitor in animal models
- (2022) N.R. Catlin et al. REPRODUCTIVE TOXICOLOGY
- Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
- (2022) Daniel W. Kneller et al. Nature Communications
- Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19
- (2022) Hengrui Liu et al. Nature Communications
- An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron
- (2022) Bao-Xue Quan et al. Nature Microbiology
- The structure-based design of peptidomimetic inhibitors against SARS-CoV-2 3C like protease as Potent anti-viral drug candidate
- (2022) Hao Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease Mpro and Papain-like Protease PLpro of SARS-CoV-2
- (2022) Lucianna H. Santos et al. Journal of Chemical Information and Modeling
- Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination
- (2022) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Genetic Surveillance of SARS-CoV-2 M pro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
- (2022) Jonathan T. Lee et al. mBio
- A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
- (2022) Subramanyam Vankadara et al. ACS Medicinal Chemistry Letters
- A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
- (2022) Hiroshi Mukae et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases
- (2022) Nikos Kühl et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals
- (2022) Yuying Ma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
- (2022) Yugendar R. Alugubelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations
- (2022) Ryan P. Joyce et al. MEDICINAL CHEMISTRY RESEARCH
- Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen
- (2022) Liying Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors
- (2022) Santo Previti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of a Dual-Targeted Covalent Inhibitor Against Papain-like and Main Proteases of SARS-CoV-2
- (2022) Wenying Yu et al. Journal of Medicinal Chemistry
- Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2
- (2022) Santanu Mondal et al. Journal of the American Chemical Society
- Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system
- (2022) Yuyong Zhou et al. Science Advances
- The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
- (2021) Wei-Chung Chiou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
- (2021) Hongbo Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
- (2021) Wei-Chung Chiou et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
- (2021) Jia-Tsrong Jan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
- (2021) Gordon J. Lockbaum et al. Viruses-Basel
- Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
- (2021) Vicky Mody et al. Communications Biology
- Re(I) Tricarbonyl Complexes as Coordinate Covalent Inhibitors for the SARS‐CoV‐2 Main Cysteine Protease
- (2021) Johannes Karges et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors
- (2021) Julian Breidenbach et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
- (2021) Jeremy D. Baker et al. PLoS One
- Bepridil is potent against SARS-CoV-2 in vitro
- (2021) Erol C. Vatansever et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
- (2021) Chunlong Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model
- (2021) Jingxin Qiao et al. SCIENCE
- A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2021) Shin-ichiro Hattori et al. Nature Communications
- Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases
- (2021) Zinuo Chen et al. Cell and Bioscience
- The Preclinical Inhibitor GS441524 in Combination with GC376 Efficaciously Inhibited the Proliferation of SARS-CoV-2 in the Mouse Respiratory Tract
- (2021) Yuejun Shi et al. Emerging Microbes & Infections
- Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19
- (2021) Kas Steuten et al. ACS Infectious Diseases
- Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
- (2021) Yanmei Hu et al. ACS Infectious Diseases
- Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
- (2021) Chun-Hui Zhang et al. ACS Central Science
- Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus
- (2021) Nabil A. Alhakamy et al. Pharmaceuticals
- Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches
- (2021) Hossam M. Abdallah et al. Pharmaceuticals
- ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
- (2021) Koen Vandyck et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Discovery of novel inhibitors against main protease (Mpro) of SARS-CoV-2 via virtual screening and biochemical evaluation
- (2021) Sheng Guo et al. BIOORGANIC CHEMISTRY
- Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2
- (2021) Ashuai Du et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening
- (2021) Giorgio Amendola et al. Journal of Chemical Information and Modeling
- Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2
- (2021) Wenhao Dai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
- (2021) Naoya Kitamura et al. JOURNAL OF MEDICINAL CHEMISTRY
- Olive-Derived Triterpenes Suppress SARS COV-2 Main Protease: A Promising Scaffold for Future Therapeutics
- (2021) Hani A. Alhadrami et al. MOLECULES
- X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
- (2021) Sebastian Günther et al. SCIENCE
- Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
- (2021) Lukas van de Sand et al. Viruses-Basel
- The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro
- (2021) Raphael J. Eberle et al. Viruses-Basel
- Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
- (2021) C. Joaquín Cáceres et al. Scientific Reports
- Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture
- (2021) Khushboo Bafna et al. Cell Reports
- Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir
- (2021) Ho Sing Lo et al. ACS Central Science
- Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics
- (2021) Hani A. Alhadrami et al. Antibiotics-Basel
- Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
- (2021) Bruno Rizzuti et al. Biomedicines
- Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro
- (2021) Ruikun Du et al. ANTIVIRAL RESEARCH
- Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
- (2021) Jennifer C. Milligan et al. BIOCHEMICAL JOURNAL
- Promising anti-SARS-CoV-2 drugs by effective dual targeting against the viral and host proteases
- (2021) Samia A. Elseginy et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
- (2021) Le-Yun Sun et al. BIOORGANIC CHEMISTRY
- Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay
- (2021) Jennifer Loschwitz et al. BIOORGANIC CHEMISTRY
- Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization
- (2021) Veronica Di Sarno et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
- (2021) Yuan Xiong et al. FITOTERAPIA
- Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro
- (2021) Ruyu Wang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms
- (2021) Yuan Xiong et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity
- (2021) Rania Hamdy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery of Novel Small-Molecule Inhibitors of SARS-CoV-2 Main Protease as Potential Leads for COVID-19 Treatment
- (2021) Anjela Manandhar et al. Journal of Chemical Information and Modeling
- Structure-Based Discovery of Novel Nonpeptide Inhibitors Targeting SARS-CoV-2 Mpro
- (2021) Jingyi Yang et al. Journal of Chemical Information and Modeling
- Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)
- (2021) Sang Hoon Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- Indole Chloropyridinyl Ester-Derived SARS-CoV-2 3CLpro Inhibitors: Enzyme Inhibition, Antiviral Efficacy, Structure–Activity Relationship, and X-ray Structural Studies
- (2021) Arun K. Ghosh et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
- (2021) Sho Konno et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
- (2021) Bing Bai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease
- (2021) Chamandi S. Dampalla et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay
- (2021) Woo Dae Jang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors
- (2021) Srinivas Chamakuri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
- (2021) Chamandi S. Dampalla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
- (2021) Nir Drayman et al. SCIENCE
- Structure-guided design of a perampanel-derived pharmacophore targeting the SARS-CoV-2 main protease
- (2021) Maya G. Deshmukh et al. STRUCTURE
- Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
- (2021) Chun-Hui Zhang et al. ACS Medicinal Chemistry Letters
- Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
- (2021) Haixia Su et al. Nature Communications
- Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
- (2021) Kangsa Amporndanai et al. Nature Communications
- Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
- (2021) Malina A. Bakowski et al. Nature Communications
- Ethacridine inhibits SARS-CoV-2 by inactivating viral particles
- (2021) Xiaoquan Li et al. PLoS Pathogens
- Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 Mpro Inhibitors from Penicillium citrinum TDPEF34
- (2021) Bathini Thissera et al. Biomolecules
- Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor
- (2021) Hani A. Alhadrami et al. Pharmaceuticals
- The Mpro structure-based modifications of ebselen derivatives for improved antiviral activity against SARS-CoV-2 virus
- (2021) Zhen Qiao et al. BIOORGANIC CHEMISTRY
- Structure‐Activity Studies Reveal Scope for Optimisation of Ebselen‐Type Inhibition of SARS‐CoV‐2 Main Protease
- (2021) Siegfried T. D. Thun‐Hohenstein et al. ChemMedChem
- Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors
- (2021) Julia K. Stille et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies
- (2021) Wayne Vuong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors
- (2021) Jiahua Cui et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 9,10-dihydrophenanthrene derivatives as SARS-CoV-2 3CLpro inhibitors for treating COVID-19
- (2021) Jian-Wei Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Indomethacin-based PROTACs as pan-coronavirus antiviral agents
- (2021) Jenny Desantis et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
- (2021) Elisa Costanzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Noncovalent Inhibitor
- (2021) Austin Clyde et al. Journal of Chemical Information and Modeling
- Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors
- (2021) Sarah Huff et al. JOURNAL OF MEDICINAL CHEMISTRY
- Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens
- (2021) Henry R. O’Donnell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural, Electronic, and Electrostatic Determinants for Inhibitor Binding to Subsites S1 and S2 in SARS-CoV-2 Main Protease
- (2021) Daniel W. Kneller et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design of Potent Inhibitors of SARS-CoV-2 3CL Protease: Structural, Biochemical, and Cell-Based Studies
- (2021) Chamandi S. Dampalla et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity
- (2021) Chunlong Ma et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus
- (2021) Yuting Zhang et al. JOURNAL OF VIROLOGY
- Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors
- (2021) Arun K. Ghosh et al. MOLECULES
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
- (2021) Runming Wang et al. Chemical Science
- Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors
- (2021) Dmitriy Shcherbakov et al. ACS Medicinal Chemistry Letters
- Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
- (2021) Britton Boras et al. Nature Communications
- Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays
- (2021) Chunlong Ma et al. Acta Pharmaceutica Sinica B
- Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo
- (2021) Otávio Augusto Chaves et al. Pharmaceuticals
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
- (2020) Jared S. Morse et al. CHEMBIOCHEM
- Recent discovery and development of inhibitors targeting coronaviruses
- (2020) Thanigaimalai Pillaiyar et al. DRUG DISCOVERY TODAY
- α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
- (2020) Linlin Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Can we contain the COVID-19 outbreak with the same measures as for SARS?
- (2020) Annelies Wilder-Smith et al. LANCET INFECTIOUS DISEASES
- Responding to Covid-19 — A Once-in-a-Century Pandemic?
- (2020) Bill Gates NEW ENGLAND JOURNAL OF MEDICINE
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
- (2020) Arun K. Ghosh et al. ChemMedChem
- COVID-19 and Multiorgan Response
- (2020) Sevim Zaim et al. CURRENT PROBLEMS IN CARDIOLOGY
- Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
- (2020) Xin Li et al. Journal of Hematology & Oncology
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
- (2020) Su-Jin Park et al. mBio
- Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
- (2020) Xiaoyan Liu et al. Acta Pharmaceutica Sinica B
- Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
- (2020) Hai-xia Su et al. ACTA PHARMACOLOGICA SINICA
- Discovery of M Protease inhibitors encoded by SARS-CoV-2
- (2020) Hui-Chen Hung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
- (2020) Natalia Fintelman-Rodrigues et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
- (2020) Olga Abian et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice
- (2020) Athri D. Rathnayake et al. Science Translational Medicine
- Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry
- (2020) Zachary A. Gurard-Levin et al. ANTIVIRAL RESEARCH
- Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage
- (2020) Tzu-Hau Shi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
- (2020) Wioletta Rut et al. Nature Chemical Biology
- Biochemical screening for SARS-CoV-2 main protease inhibitors
- (2020) Camila Coelho et al. PLoS One
- Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
- (2020) Zhe Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals
- (2020) Daniel W. Kneller et al. STRUCTURE
- GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
- (2020) Shin-ichiro Hattori et al. mBio
- Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
- (2020) Mohammad M. Ghahremanpour et al. ACS Medicinal Chemistry Letters
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
- (2020) Xuping Xie et al. Nature Communications
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2020) Wayne Vuong et al. Nature Communications
- A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**
- (2020) Kai S. Yang et al. ChemMedChem
- Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
- (2020) Praveen Kumar Tripathi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease
- (2020) Akshita Gupta et al. ACS Omega
- Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode
- (2020) Jian Li et al. Science Bulletin
- Chemical synthesis, crystal structure, versatile evaluation of their biological activities and molecular simulations of novel pyrithiobac derivatives
- (2019) Ren-Jun Wu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
- (2019) Mélissanne de Wispelaere et al. Nature Communications
- Inhibition of SARS-CoV 3CL protease by flavonoids
- (2019) Seri Jo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor
- (2019) Shin-ichiro Yoshizawa et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor
- (2018) Kouji Ohnishi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study
- (2017) Li Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors
- (2016) Vathan Kumar et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
- (2016) Hiroyuki Konno et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
- (2015) Yasuhiro Shimamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY
- SARS-CoV 3C-Like Protease Inhibitors of some Newly Synthesized Substituted Pyrazoles and Substituted Pyrimidines Based on 1-(3-Aminophenyl)-3-(1H-indol-3-yl)prop-2-en-1-one
- (2015) Salwa F. Mohamed et al. International Journal of Pharmacology
- Chalcones isolated fromAngelica keiskeiinhibit cysteine proteases of SARS-CoV
- (2015) Ji-Young Park et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Middle East respiratory syndrome
- (2015) Alimuddin Zumla et al. LANCET
- Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava
- (2013) Ji-Young Park et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings
- (2013) Hyun Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors
- (2013) Wei Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
- (2013) Mark Turlington et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and Biological Evaluation of Quinolinone Compounds as SARS CoV 3CLproInhibitors
- (2013) Yuanpei Sun et al. CHINESE JOURNAL OF CHEMISTRY
- Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
- (2013) Pillaiyar Thanigaimalai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
- (2013) Pillaiyar Thanigaimalai et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations
- (2013) E. E. Walsh et al. JOURNAL OF INFECTIOUS DISEASES
- Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
- (2012) Ji-Young Park et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
- (2012) Sho Konno et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
- (2012) Thi Thanh Hanh Nguyen et al. BIOTECHNOLOGY LETTERS
- Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
- (2012) Chi-Pang Chuck et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
- (2012) Jon Jacobs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Seven Novel Mammalian and Avian Coronaviruses in the Genus Deltacoronavirus Supports Bat Coronaviruses as the Gene Source of Alphacoronavirus and Betacoronavirus and Avian Coronaviruses as the Gene Source of Gammacoronavirus and Deltacoronavirus
- (2012) P. C. Y. Woo et al. JOURNAL OF VIROLOGY
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
- (2011) Lili Zhu et al. ANTIVIRAL RESEARCH
- Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation
- (2011) Thi Thanh Hanh Nguyen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibitors of SARS-3CLpro: Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation Studies
- (2011) Prasenjit Mukherjee et al. Journal of Chemical Information and Modeling
- Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
- (2011) Kenichi Akaji et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
- (2010) Young Bae Ryu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
- (2010) R. Ramajayam et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease
- (2010) R. Ramajayam et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii
- (2010) Young Bae Ryu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and Evaluation of Benzoquinolinone Derivatives as SARS-CoV 3CL Protease Inhibitors
- (2010) Tae-Young Ahn et al. BULLETIN OF THE KOREAN CHEMICAL SOCIETY
- New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors
- (2009) Thomas Regnier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Recently Discovered Human Coronaviruses
- (2009) Brigitte A. Wevers et al. CLINICS IN LABORATORY MEDICINE
- Individual and common inhibitors of coronavirus and picornavirus main proteases
- (2009) Chih-Jung Kuo et al. FEBS LETTERS
- Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds
- (2009) Cheng-Chung Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sensitized Detection of Inhibitory Fragments and Iterative Development of Non-Peptidic Protease Inhibitors by Dynamic Ligation Screening
- (2008) Marco Florian Schmidt et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant
- (2008) Kenichi Akaji et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits
- (2008) Prasenjit Mukherjee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
- (2008) Yi-Ming Shao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
- (2008) Arun K. Ghosh et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase
- (2008) Jianmin Zhang et al. BIOORGANIC CHEMISTRY
- Design and Synthesis of Cinanserin Analogs as Severe Acute Respiratory Syndrome Coronavirus 3CL Protease Inhibitors
- (2008) Qingang Yang et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Development of Broad-Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro
- (2008) Usman Bacha et al. Chemical Biology & Drug Design
- A Structural View of the Inactivation of the SARS Coronavirus Main Proteinase by Benzotriazole Esters
- (2008) Koen H.G. Verschueren et al. CHEMISTRY & BIOLOGY
- Human coronavirus NL63 infections in infants hospitalised with acute respiratory tract infections in South Africa
- (2008) Heidi Smuts Influenza and Other Respiratory Viruses
- Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro
- (2007) Chunying Niu et al. BIOORGANIC & MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started